ecopipam has been researched along with phenoxybenzamine in 1 studies
| Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (phenoxybenzamine) | Trials (phenoxybenzamine) | Recent Studies (post-2010) (phenoxybenzamine) |
|---|---|---|---|---|---|
| 147 | 18 | 34 | 5,006 | 70 | 95 |
| Protein | Taxonomy | ecopipam (IC50) | phenoxybenzamine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 4.9 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 2.72 | |
| Solute carrier family 22 member 3 | Homo sapiens (human) | 6.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cools, AR; Ellenbroek, BA; Prinssen, EP | 1 |
1 other study(ies) available for ecopipam and phenoxybenzamine
| Article | Year |
|---|---|
Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine.
Topics: Adrenergic alpha-1 Receptor Antagonists; Analysis of Variance; Animals; Benzazepines; Clozapine; Disease Models, Animal; Dopamine Antagonists; Drug Synergism; Forelimb; Hindlimb; Ketanserin; Male; Pain Measurement; Phenoxybenzamine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Serotonin | 1994 |